Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 8.

Peniket, A., Wainscoat, J., Side, L., Daly, S., Kusec, R., Buck, G., Wheatley, K., Walker, Helen, Chatters, S., Harrison, C., Boultwood, J., Goldstone, A. and Burnett, Alan Kenneth 2005. Del (9q) AML: clinical and cytological characteristics and prognostic implications. British Journal of Haematology 129 (2) , pp. 210-220. 10.1111/j.1365-2141.2005.05445.x

Grimwade, David, Walker, Helen, Harrison, Georgina, Oliver, Fiona, Chatters, Stephen, Harrison, Christine J., Wheatley, Keith, Burnett, Alan Kenneth and Goldstone, Anthony H. 2001. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98 (5) , pp. 1312-1320. 10.1182/blood.V98.5.1312

Allford, S., Grimwade, D., Langabeer, S., Duprez, E., Saurin, A., Chatters, S., Walker, Helen, Roberts, P., Rogers, J., Bain, B., Patterson, K., McKernan, A., Freemont, P., Solomon, E. and Burnett, Alan Kenneth 1999. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. British Journal of Haematology 105 (1) , pp. 198-207. 10.1046/j.1365-2141.1999.01312.x

Langabeer, S. E., Walker, Helen, Rogers, J. R., Burnett, Alan Kenneth, Wheatley, K., Swirsky, D., Goldstone, A. H. and Linch, D. C. 1997. Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials. British Journal of Haematology 99 (4) , pp. 925-928. 10.1046/j.1365-2141.1997.4663270.x

Grimwade, D., Langabeer, S., Gorman, P., Howe, K., Duprez, E., Walker, Helen, Wheatley, K., Goldstone, A., Burnett, Alan Kenneth and Solomon, E. 1997. Molecular characterisation of patients with APL entered into the UK MRC ATRA trial: Relationship of PML breakpoint with additional cytogenetic abnormalities and outcome [Abstract]. Blood 90 (10) , p. 271.

Burnett, Alan Kenneth, Wheatley, K., Langabeer, S., Walker, Helen, Linch, D., Goldstone, A. H., Hann, I. and Stevens, R. F. 1997. Outcome of acute myeloid leukaemias affecting core binding factor subunits: the UK MRC experience. Blood 90 (10) , p. 1737.

Langabeer, S. E., Walker, Helen, Gale, R., Wheatley, K., Burnett, Alan Kenneth, Goldstone, A. H. and Linch, D. C. 1997. Frequency of CBFβ/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. British Journal of Haematology 96 (4) , pp. 736-739. 10.1046/j.1365-2141.1997.d01-2096.x

Grimwade, D., Howe, K., Langabeer, S., Walker, Helen, Smith, F., Swirsky, D., Wheatley, K., Goldstone, A., Burnett, Alan Kenneth and Solomon, E. 1995. Molecular and cytogenetic assessment of patients with acute promyelocytic leukaemia (APL) entered into the UK MRC ATRA trial [Abstract]. Blood 86 (10) , p. 1060.

This list was generated on Wed Dec 11 08:56:28 2019 GMT.